OPTOSURGICAL LLC — Department of Health and Human Services SBIR Phase II: AH04

OPTOSURGICAL LLC — SBIR Phase II award from Department of Health and Human Services.

Amount
$3,500,000
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
AH04
Solicitation
75N91023R00041
NAICS
Place of performance
DE
Period

Description

The project aims to advance the development of BL-760, a near-infrared contrast agent designed for clear intraoperative identification of bile ducts. This novel dye addresses the significant medical issue of bile duct injury during hepatobiliary surgeries (e.g., cholecystectomy, hepatectomy), impacting over 1 million patients annually. The project plans to produce BL-760 with high quality standards (GMP) and to conduct rigorous safety tests in a controlled lab environment (GLP), at the allow for Investigational New Drug (IND)-enabling studies to test the dye in humans. The project outcome will improve patient outcomes and set a new standard of care in the field of hepatobiliary surgery.